Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

U.S. stocks come off earlier lows; Dow gains 0.13%

Published 07/28/2014, 04:16 PM
Updated 07/28/2014, 04:20 PM
U.S. stocks rebound after investors take downbeat home sales report in stride

Investing.com - U.S. stocks came off earlier lows and ended mixed on Monday, with investors selling earlier on news of a disappointing pending home sales report though markets later shrugged off the data, which brought broader indices back into positive territory.

At the close of U.S. trading, the Dow 30 rose 0.13%, the S&P 500 index rose 0.03%, while the NASDAQ Composite index fell 0.10%.

The Volatility S&P 500 index, which measures the outlook for market volatility, was down 0.63% at 12.61.

Stocks pushed lower earlier after the National Association of Realtors reported that U.S. pending home sales fell 1.1% in June, disappointing expectations for a 0.5% gain.

"Activity is notably higher than earlier this year as prices have moderated and inventory levels have improved," National Association of Realtors chief economist Lawrence Yun said in a statement.

"However, supply shortages still exist in parts of the country, wages are flat, and tight credit conditions are deterring a higher number of potential buyers from fully taking advantage of lower interest rates."

The data sent investors selling stocks ahead of the Federal Reserve's policy statement on Wednesday and the July jobs report due out on Friday.

Still, after comparing the report with upbeat durable goods, weekly jobless claims and new home sales reports from last week as well as a string of upbeat earnings, stocks climbed back into positive territory for the most part.

Mergers and acquisitions news bolstered equities as well.

Dollar Tree Inc (NASDAQ:DLTR) announced plans to acquire rival Family Dollar Stores Inc (NYSE:FDO), while online real estate portal Zillow Inc (NASDAQ:Z) said it would buy rival Trulia Inc (NYSE:TRLA) for $3.5 billion in cash and stock.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Elswhere, AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) failed to win Food and Drug Administration approval for its pain treatment Zalviso.

Leading Dow Jones Industrial Average performers included UnitedHealth Group Incorporated (NYSE:UNH), up 1.27%, Exxon Mobil Corporation (NYSE:XOM), up 1.16%, and Walt Disney Company (NYSE:DIS), up 1.07%.

The Dow Jones Industrial Average's worst performers included Microsoft Corporation (NASDAQ:MSFT), down 1.20%, General Electric Company (NYSE:GE), down 0.79%, and Coca-Cola Company (NYSE:KO), also down 0.79%.

European indices, meanwhile, ended the day largely lower.

After the close of European trade, the Euro Stoxx 50 fell 0.13%, France's CAC 40 rose 0.33%, while Germany's DAX 30 fell 0.48%. Meanwhile, in the U.K. the FTSE 100 fell 0.05%.

On Tuesday, the U.S. is to publish reports on house price inflation and consumer confidence.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.